- Open Access
Lipid raft/caveolae signaling is required for Cryptococcus neoformans invasion into human brain microvascular endothelial cells
Journal of Biomedical Science volume 19, Article number: 19 (2012)
Cryptococcus neoformans has a predilection for central nervous system infection. C. neoformans traversal of the blood brain barrier, composed of human brain microvascular endothelial cells (HBMEC), is the crucial step in brain infection. However, the molecular mechanism of the interaction between Cryptococcus neoformans and HBMEC, relevant to its brain invasion, is still largely unknown.
In this report, we explored several cellular and molecular events involving the membrane lipid rafts and caveolin-1 (Cav1) of HBMEC during C. neoformans infection. Immunofluorescence microscopy was used to examine the roles of Cav1. The knockdown of Cav1 by the siRNA treatment was performed. Phosphorylation of Cav1 relevant to its invasion functions was investigated.
We found that the host receptor CD44 colocalized with Cav1 on the plasma membrane, and knockdown of Cav1 significantly reduced the fungal ability to invade HBMEC. Although the CD44 molecules were still present, HBMEC membrane organization was distorted by Cav1 knockdown. Concomitantly, knockdown of Cav1 significantly reduced the fungal crossing of the HBMEC monolayer in vitro. Upon C. neoformans engagement, host Cav1 was phosphorylated in a CD44-dependent manner. This phosphorylation was diminished by filipin, a disrupter of lipid raft structure. Furthermore, the phosphorylated Cav1 at the lipid raft migrated inward to the perinuclear localization. Interestingly, the phospho-Cav1 formed a thread-like structure and colocalized with actin filaments but not with the microtubule network.
These data support that C. neoformans internalization into HBMEC is a lipid raft/caveolae-dependent endocytic process where the actin cytoskeleton is involved, and the Cav1 plays an essential role in C. neoformans traversal of the blood-brain barrier.
Cryptococcus neoformans is commonly found in the environment, such as in the soil and in bird droppings. These fungal cells may be inhaled and deposited into the lungs and into the blood stream, providing a path for C. neoformans to reach the brain. In the case of the immunocompromised, this fungus could cause life-threatening cryptococcal meningitis [1, 2]. In the world today, cryptococcal infection has become the most common fungal pathogen of the central nervous system . In order to cause meningoencephalitis, the fungal cells must cross the blood-brain barrier (BBB). A special type of cell constitutes the BBB, the brain microvascular endothelial cells (BMEC), which are characterized by extremely tight intercellular junctions . The large surface of BMEC exposed to blood circulation (~20 m2 per human brain) underscores the importance of the BBB as the critical limiting factor for C. neoformans brain invasion.
Infection of C. neoformans into human brain microvascular endothelial cells (HBMEC) requires adherence to the host cell's surface in order to resist the flow of blood. It is generally accepted that the fungal capsule is the major virulence factor of this pathogen (reviewed by ). Real-time images have shown that the C. neoformans cells may become trapped within the microvessels in the brain, and subsequently, enter into the brain through the parenchyma . Several mechanisms are possible for this transmigration process [6–12]. For example, hyaluronic acid (HA), produced by the hyaluronic acid synthase gene (CPS1) of C. neoformans, plays a role in the adhesion of the fungal cells to endothelial cells [9, 13]. We have demonstrated that HBMEC CD44 is the primary receptor for C. neoformans infection . Accordingly, the adherence of C. neoformans in the circulating blood to BMEC may be secured by the C. neoformans-produced HA and HBMEC CD44 interaction (the adhesion step). Then, the fungal cell triggers host signaling pathway(s) to facilitate its internalization (the invasion step). One feature of this process is the ability of C. neoformans to induce morphological changes in HBMEC, such as: membrane ruffling, irregular nuclear morphology and swelling of the mitochondria and the ER . These findings suggest that C. neoformans is able to induce actin cytoskeletal reorganization of the host cells. Furthermore, activation of host PKCα is essential for C. neoformans internalization into HBMEC . During C. neoformans infection, PKCα activation by phosphorylation is induced and PKC enzymatic activity is detected in the HBMEC membrane fraction. PKCα activation is a CPS1/CD44-dependent process. Blockage of PKCα function attenuates actin filament activity during C. neoformans invasion. Moreover, treatment with cytochalasin D, an actin disrupting reagent, can effectively block C. neoformans invasion into HBMEC in vitro . Thus, the host PKCα action on C. neoformans internalization into HBMEC may be mediated via actin filament activity.
C. neoformans invasion into HBMEC is sensitive to the filipin treatment , which extracts cholesterol from membrane lipid rafts. It is generally accepted that endocytosis is mediated by membrane lipids or rafts. We have found that, in the presence of C. neoformans, the HBMEC lipid raft marker ganglioside GM1 can influx into the cytosol and accumulate in the perinuclear region . The uptake of GM1 suggests the involvement of lipid raft endocytic pathways. An intriguing question raised is how C. neoformans builds its distinct uptake mechanism via lipid raft endocytic routes. This question is complicated by the fact that endocytosis is comprised of multiple mechanisms, i.e., caveolae-dependent, clathrin-dependent mechanisms, pinocytosis, macropinocytosis, and phagocytosis [17–19]. Upon C. neoformans and HBMEC engagement, a subpopulation of CD44, Cav1, and actin translocates to the host membrane rafts . This link to dynamic caveolin trafficking suggests that caveolae may play a role during the adhesion and entry of C. neoformans at HBMEC membrane rafts.
Caveolae are small invaginations in the plasma membrane that mediate multiple functions, including signal transduction and endocytosis [19, 20] and are characterized by the marker protein caveolins . The mammalian caveolin family contains three members: caveolin-1, -2, and -3. Caveolin-2 is unable to form oligomers without Cav1. Caveolin-3 (M-caveolin) is a muscle specific member. Thus, Cav1 could be the critical caveolin in HBMEC. Cav1 is also known as VIP21 (Vesicular Integral-membrane Protein of 21 kD); indeed, the protein appears not only in the plasma membrane, but also on the Golgi-apparatus and vesicular membrane structures. The N-terminal region Cav1 contains the caveolin scaffolding domain (CSD; residues 82-101), which is essential for the formation of caveolin oligomers as well as interaction with other proteins. Abundant information reveals that caveolin participates in many important cellular processes, including vesicular trafficking, cholesterol homeostasis, cell adhesion and apoptosis . Caveolins also interact with multiple signaling molecules, and so, it is believed that caveolins serve as scaffolding proteins for the integration of signal transduction. At least 37 proteins have been identified to interact with the CSD domain of caveolin . Moreover, some reports suggest that the activity of caveolins seems to be dependent on their specific post-translational modifications, which then allow them to modulate cellular signaling cascades. For example, the palmitoylation of Cav1 at a single site (Cys156) was shown to be necessary for the coupling of Cav1 to c-Src tyrosine kinase . Also, phosphorylation at Tyr14 is essential for caveolin association with SH2 or PTB domain-containing adaptor proteins, such as GRB7 . It is suggested that Cav1 stabilizes caveolae at the plasma membrane and thereby acts as a negative regulator of the internalization of caveolae or lipid raft-like membrane domains . Upon phosphorylation of caveolin, caveolae are induced and then internalized by endocytosis. However, the detailed mechanism of this process remains to be further elucidated.
Our previous studies demonstrated that C. neoformans adhesion to HBMEC takes place on the lipid rafts and Cav1 may take part in the invasion process . However, the role of caveolin during C. neoformans infection has never been tested. In this report, we first examined the impact of Cav1-knockdown on host receptor CD44 functions and on lipid rafts. Concurrently, the knockdown of Cav1 significantly reduced C. neoformans invasion and the crossing of the HBMEC monolayer in vitro. We further examined the phosphorylation regulation of Cav1 in response to C. neoformans invasion. Our studies are the first to demonstrate that phosphorylated Cav1 migrates inward in HBMEC along with actin filaments but not with the microtubule cytoskeleton. Together, our results suggest that C. neoformans invasion into HBMEC is linked to the lipid raft/caveolae-dependent endocytotic process and that Cav1 plays an essential role during this invasion process.
C. neoformans strains, media and cultures
The C. neoformans strain B-4500FO2 is the parental strain used mainly in this report [9, 13]. C559 is an isogenic deletion mutant of the CPS1 gene, which is derived from strain B-4500FO2. C1186 is a strain B-4500FO2 with a stable expression of GFP. This strain was used in Figure 1 for the purpose of showing the interaction between C. neoformans (green) and HBMEC (red). In Figure 2C, the Cav1-GFP showed a green signal, therefore strain B-4500FO2 was used to stain with anti-GXM antibody and the 2nd antibody conjugated with rhodamine (red). C. neoformans cells were grown aerobically at 30°C in 1% yeast extract, 2% peptone and 2% dextrose (YPD broth)(Difco Laboratories, Detroit, MI). Cells were harvested at early log phase, washed with phosphate-buffered saline (PBS) and resuspended in Hams-F12/M199 (1:1, v:v), 5% heat-inactivated fetal bovine serum (experimental medium), and 1% human serum. The Cryptococcus cell number was determined by direct counting from a hemocytometer .
HBMEC were isolated and cultured as described previously . HBMEC cultures were maintained in RPMI 1640 medium containing 10% heat-inactivated fetal bovine serum, 10% NuSerum (BD Bioscience, Bedford, MA), 2 mM glutamine, 1 mM sodium pyruvate, 100 μg/ml streptomycin, 100 units/ml penicillin, essential amino acids, and vitamins. The cells were washed before performing experiments. The expression vector with the Cav1-GFP was obtained from Addgene, Inc (plasmid #14433). The plasmid was transfected into HBMEC using neomycin for selection.
Samples for immunofluorescence microscopy were prepared as follows. HBMEC were plated onto glass coverslips (22 mm, square), which had been previously coated with type I collagen from rat tail (Upstate, 5-10 μg/cm2) in an 8-well square culture system (Nalgene Nunc). HBMEC (~5 × 104 cells) were seeded onto one coverslip 24 h prior to the experiment. HBMEC were prewashed four times with PBS, then fixed with 2% formaldehyde/PBS (v:v) for 30 min at room temperature. After additional three-washes with PBS, the HBMEC were blocked with 5% milk/PBS for 30 min and then incubated with antibody or proper reagent at 4°C overnight. Anti-CD44 monoclonal antibody was purchased from Santa Cruz (used at 1:500 dilution); Cholera toxin subunit B (CTxB)-FITC was purchased from Sigma Chem. Co. (#C1655, 1~2 μg/mL); anti-Cav1(tyr-14) was purchased from Cell Signaling Technology (#3251); actin filaments were stained with phalloidin-rhodamine conjugate (Sigma Chem Co. cat #P1951), and anti-tubulin antibody was obtained from Sigma Chem Co., (#T5168). Anti-GXM monoclonal antibody 18B7 was used to stain the fungal cell (kindly provided by Dr. Casadevall, Albert Einstein College of Medicine). The coverslips were then washed 4 times with PBS, then 1% BSA/PBS and/or anti-mouse IgG FITC conjugate (1:100 dilution) was added into each well for 1 h at 4°C. Another three washes were applied, then a drop of Vectashield mounting solution containing DAPI (Vector Laboratories; H-120) was used to seal the coverslips onto slides. Samples were examined under a fluorescence microscope at the Congressman Dixon Cellular Imaging Core Facility, Children's Hospital Los Angeles.
In vitro adhesion and invasion assays
Immunofluorescence microscopy was used for the in vitro adhesion and invasion assays, as described previously . Briefly, the HBMEC were probed with β-actin using phalloidin-rhodamine conjugate to display a red background. C. neoformans C1186 cells show a bright green fluorescence. After 3 hr incubation, the slides were prepared for immunofluorescence imaging. Individual green C. neoformans cells were observed clearly by immunofluorescence microscopy. For those adherent C. neoformans cells, the green signals from C1186 partially overlapped with the red-stained HBMEC and thus displayed the green/yellow signals. For invaded C. neoformans cells, the internalized C. neoformans cells bearing GFP were totally overlapped with red background and thus showed a complete yellow signal. The total adherent (Figure 3A) or invaded (Figure 3B) C. neoformans cells of the untreated samples were designated as 100%. Five random regions in the chamber slide in each sample were counted under the microscope. The assay for each experiment was reproduced at least 3 times.
In vitro transcytosis assay
C. neoformans in vitro transcytosis assays were performed as described previously [14, 15]. Briefly, HBMEC were cultured on collagen-coated Transwell polycarbonate tissue culture inserts with a pore diameter of 12 μm (Corning Costar) for 24 h. Triple samples of HBMEC were pretreated with Cav1 siRNA (0, 10 and 20 pmoles in 0.5 mL culture medium) individually for an additional 48 h. HBMEC were polarized and exhibited a trans-endothelial electrical resistance (TEER) of 250~300 μΩ per cm2, as measured with an Endohm volt/ohm meter (World Precision Instruments). On the morning of the assay, HBMEC monolayers were washed with experimental medium and 106 Cryptococcus cells were added to the upper chamber (total volume 500 μl); they were then incubated at 37°C. At 4 and 8 h, samples (100 μl) were taken from the lower chamber and plated for counting of CFU. The lower chamber was replenished with 100 μl fresh culture medium. Simultaneously, the integrity of the HBMEC monolayer was assessed by measurement of the TEER. Three measurements were made at each time-point for each sample.
Cav1 knockdown experiments
Cav1 siRNA was purchased from Santa Cruz Biotech (#sc-29241), and a control oligo (#sc-36869) was used in parallel as the control. Cav1 siRNA treatment is according to the manufacturer's protocol. Briefly, 0, 10, 20 pmoles siRNA (or indicated concentrations) was transfected into HBMEC, using SuperFection TM siRNA Transfection Reagent (cat.# SL100559) from SignaGen® Lab (Gaithsburg, MD). After 5 h, the culture was replaced with fresh medium and grown for another 24 h. Then the HBMEC were washed with PBS three times before the experiments. One set of sample was used to detect the Cav1 protein level (Figure 2A), and another set of treated HBMEC was used for several studies. Similar preparations were performed for immunofluorescence microscopic studies (Figures 1, 2B, & 2C), in vitro adhesion and invasion assays (Figure 3), and the transcytosis assay (Figure 4).
The statistical analysis of the data from our in vitro studies involved analysis of variance (ANOVA). The dependent variable was the associated percent of cells or CFU while the independent fixed factors were the treatments (Cav1 siRNA). Raw data was entered into EXCEL files and automatically converted to statistical packages. ANOVA and co-variates were followed by the Newmann-Keuls test, to determine the statistical significance between the control and treatment groups. P < 0.05 was considered to be significant.
Colocalization of Cav1-GFP and CD44 on the surface of HBMEC
We have previously demonstrated that the HBMEC CD44 plays the key role as the host receptor during C. neoformans invasion . Upon C. neoformans association, both CD44 and Cav1 translocate to the surface membrane rafts. However, the relationship between CD44 and Cav1 is still not clear. As Cav1 is a major structural and functional protein component of caveolae/lipid rafts, we would like to clarify the relationship of these two proteins during C. neoformans infection. We first detected whether there is a colocalization between Cav1 and CD44 molecules on the membrane of HBMEC. DAPI stain (blue) was used to locate HBMEC cells (Figure 5a). Cav1-GFP has been verified as a reliable marker for endogenous Cav1 , thus we used it to represent its localization (Figure 5b). In general, Cav1 can be found on the plasma membrane, peri-centrosomal caversomes around the nucleus, and caveolae vesicles in the cytosol. Its localization in HBMEC is similar to the observation in CHO cells . CD44 is located both on the plasma membrane and in the cytosol (Figure 5c). In an overlaid image, there are colocalizations of Cav-1-GFP and CD44 in some areas on the plasma membrane (10~15%) (Figure 5d, arrows), as illustrated by the bright yellow signals. No or little colocalization of CD44 and Cav1 was observed inside the HBMEC.
Effect of anti-Cav1 siRNA on HBMEC during C. neoformans infection
Infection of C. neoformans into HBMEC first requires initial adherence to the host cell surface resulting in the triggering of the host cell's signaling pathway(s) to facilitate its internalization. We investigated whether the knockdown of Cav1 with siRNA would affect CD44 function and/or C. neoformans invasion into HBMEC. A random oligo and buffer alone were used in parallel as controls. After 24 h of treatment, one set of samples was used to detect the Cav1 protein level (Figure 2A). Under our experimental conditions, ~60% of the endogenous Cav1 was knocked down in the Cav1 siRNA-treated HBMEC (Figure 2A, lane 3) compared to the controls (Figure 2A, lanes 1 & 2). Another set of samples was used for immunofluorescence images to examine Cav1 using anti-Cav1 antibodies with rhodamine conjugate (red) in the Cav1-knockdown HBMEC. As shown in Figure 2B, there are several DAPI stains void of Cav1 signals; presumably these are Cav1-knockdown HBMEC cells. Although limited, Cav1 signal can be detected in some HBMEC cells. These signals are either significantly reduced or display a more diffused distribution in HBMEC. The overall reduction of Cav1 signal is consistent with protein blotting studies (Figure 2A).
To further examine the alterations in Cav1-knockdown HBMEC, we used cholera toxin subunit B (CTxB)-FITC conjugate to locate the membrane raft marker ganglioside GM1. In the absence of C. neoformans, the GM1 signal was weak (Figure 2C, left, upper panel). Correspondingly, the signal increases, particularly on the membrane portion, in the presence of C. neoformans. However, in the Cav1 siRNA-treated HBMEC, the signal of GM1 was weak and void of membrane staining (Figure 2C, right panels). Despite the signal increases in the presence of C. neoformans cells, there is no noticeable redistribution of GM1 on the surface of Cav1 KO HBMEC in the siRNA treated HBMEC (Figure 2C, right panels). Analysis of variance shows significant increases in GM1 signal in the presence of C. neoformans cells (P = 0.0029), but not much different in the siRNA treated samples (Figure 2D). Thus, lack of Cav1 might prevent the reorganization of membrane lipid rafts of HBMEC in response to C. neoformans infection.
Perturbation of CD44 distribution on HBMEC plasma membrane after Cav1 siRNA treatment
We next explored if there was any effect on the distribution of CD44 on the Cav1 knockdown HBMEC. Through the immunofluorescent staining, the control (CD44 without C. neoformans cells) is depicted by a vivid contour on the membrane (Figure 1, upper, left panel). In contrast, the CD44 signals increase and clusters on the membrane in the presence of C. neoformans strain C1186 cells (Figure 1, upper, right panel), particularly around the C. neoformans adhesion site. Interestingly, the Cav1 knockdown HBMEC displayed a very unique phenotype i.e., the CD44 stains become irregularly diffused throughout the surface (Figure 1, bottom panels), regardless of the presence or absence of C. neoformans cells (Figure 1, left vs. right bottom panels). The magnified images were displayed in the lower bottom panels. It seems that CD44 loses its organization and becomes concentrated in islands on the surface of HBMEC after Cav1 is knocked down. However, the total CD44 intensity seems unchanged. This unique phenotype leads us to inquire: (1) can these CD44 molecules in the Cav1 siRNA-treated HBMEC still act as functional receptors for the adherence of C. neoformans cells, and (2) can C. neoformans cells still invade into Cav1 siRNA-treated HBMEC? These questions are addressed below.
Effect of Cav1 siRNA on the adhesion and invasion of C. neoformans into HBMEC
We speculated that knockdown of Cav1 may have some profound effects on the CD44 receptor function, therefore, we used in vitro adhesion and invasion assays to study C. neoformans infection on Cav1 knockdown HBMEC . Untreated HBMEC or HBMEC treated with control oligo were used in parallel (Figure 3A, lanes 1 and 2). We found that the association of C. neoformans with HBMEC was reduced only slightly in the Cav1 siRNA-treated HBMEC (Figure 3A, lane3). Presumably, C. neoformans cells can adhere to the surface of HBMEC, as the CD44 molecules are still present. On the other hand, the number of invaded fungal cells was significantly reduced in Cav-1 siRNA-treated HBMEC (Figure 3B, lane 3), suggesting that C. neoformans cells attached on the surface of HBMEC but failed to internalize into the Cav1 knockdown host cells. In this regard, the interaction between fungal cells and the host CD44 appears to be effective; however, the Cav1 siRNA-disrupted of caveolae/lipid raft structures may not be able to organize into an effective fungal entry site. Alternatively, the reduction of Cav1 molecules may not be able to trigger sufficient host signaling for C. neoformans internalization.
Effect of Cav1 siRNA on C. neoformans traversal across the HBMEC monolayer in vitro
We have set up an in vitro blood-brain barrier model to study how C. neoformans cells traverse the HBMEC monolayer [10, 14]. HBMEC were seeded on the collagen-coated transwell filter and treated with the control oligonucleotide and Cav1 siRNA in parallel for comparison. The transendothelial electric resistance (TEER) was used to monitor the intactness of the tight junction of HBMEC monolayer. In general, the TEER was maintained around 250~300 μΩ throughout the experiments, indicating that the tight junctions were maintained during the study (data not shown). Our results showed the ability of C. neoformans to traverse the monolayer was significantly decreased in the absence of Cav1 (Figure 4), suggesting that Cav1 is crucial for the C. neoformans penetration through the blood-brain barrier. Taken together, our results support that Cav1 is not only required for the integrity of membrane raft structure (Figure 1), but also responsible for C. neoformans internalization (Figures 3). These functions are crucial for C. neoformans cells to cross the blood-brain barrier (Figure 4), a process which may subsequently lead to central nervous system infection.
Distribution of phosphorylated Cav1 on HBMEC during C. neoformans infection
It has been suggested that, upon external stimulus, caveolin may be activated through its phosphorylation regulation [27, 28]. Limited information is available regarding the Cav1 phosphorylation regulation in relation to pathogen invasions . So, we explored this regulation in HBMEC during C. neoformans infection. We first performed the time-course studies of Cav1 during C. neoformans infection to evaluate its phosphorylation in HBMEC. Using anti-phospho-Tyr-14 Cav1 specific antibodies, we detected a basal level of phosphorylated Cav1 (Pi-Cav1) at the zero time point, suggesting that the internalization of caveolae is already active for certain normal cellular functions in HBMEC (Figure 6A). Upon C. neoformans treatment, the Pi-Cav1 increased at 5 min and peaked at least 5-fold above basal level at 10 min. Thus, C. neoformans is able to significantly induce Cav1 phosphorylation, presumably resulting in its activation.
We further used immunofluorescence microscope to investigate the Pi-Cav1 dynamics in response to C. neoformans infection. In the absence of C. neoformans, the basal level of the Pi-Cav1 could be observed in the perinuclear regions in the cytosol (Figure 6B-1). Unlike total Cav1 distribution shown in Figure 5, little or no Pi-Cav1 signal was detected in the plasma membrane of HBMEC. In the presence of C. neoformans (5 min), some membrane signals can be detected, but more significantly, many linear array structures of Pi-Cav1 signals were observed inside the HBMEC (Figure 6B-2). In a prolonged incubation (60 min), a mixed population of Pi-Cav1 staining can be observed (Figure 6B-3). In some cells, the cytosolic Pi-Cav1 displayed small vesicle structures (dots); however, the linear arrays are more obvious. In other cells, the perinuclear localization can be observed, suggesting the terminal location of Pi-Cav1. Thus, membrane Cav1 may be phosphorylated, internalized and accumulated in the perinuclear region of HBMEC. The linear structure may represent its functions in shuttling caveolae or caveolae-like membrane vesicles between plasma membrane and caveosome around the peri-centrosomal region .
To further examine its phosphorylation regulation, C. neoformans isogenic CPS1 strains were used. C. neoformans strain B-4500FO2 (CPS1+) could, but strain C559 (cps1 Δ) could not, enhance the Pi-Cav1 signal (Figure 7A). Since C559 is defective in the biosynthesis of hyaluronic acid (HA), we then tested whether HA by itself could stimulate the phosphorylation of Cav1. As shown in Figure 7A (lines 4, 5), the Cav1 phosphorylation was increased in a hyaluronic acid-dependent manner. Thus, phosphorylation regulation of Cav1 is an HA-CD44 dependent process.
Filipin was used to perturb the membrane lipid raft structure on HBMEC. Cav1 phosphorylation was stimulated by C. neoformans B-4500FO2 first, but this induced phosphorylation level was decreased as the filipin concentration increased (Figure 7B). Therefore, the filipin treatment reduced an already induced level of phophorylation, and/or prevented the C. neoformans-induction of phosphorylation. These results suggest that Cav1 phosphorylation might take place at the membrane lipid rafts and/or that Cav1 phosphorylation requires an intact membrane raft structure.
Colocalization of Pi-Cav1 with β-actin, but not with tubulin, during internalization
During endocytosis, endosomal trafficking is required both the actin cytoskeleton and microtubules . However, how they are linked to Pi-Cav1 dynamics has never been explored. To further explore the nature of the linear array structure observed in Figure 6B, we examined the relationship between Pi-Cav1, actin and the microtubules. HBMEC were incubated with B-4500FO2 (CPS1+) at 0, 5 and 60 min and then probed for nuclear DNA, β-actin and Pi-Cav1. DAPI stains nuclear DNA (blue) to locate the individual HBMEC cell (Figure 8, first column). β-Actin molecules were stained by the phalloidin-rhodamine conjugate (red) (Figure 8, second column), and Pi-Cav1 was stained with a specific antibody conjugated with FITC (green) (Figure 8, third column). At the 5 min incubation period, the effect of C. neoformans on β-actin (red) and phospho-Cav1 (green) could be observed. Both signals increased and thread-like structures became more obvious throughout the HBMEC. The stress fibers of actin filaments are well known, but the thread-like fibers of Pi-Cav1 have never been described. At 60 min, similar structures could be observed, except that β-actin showed stronger signals on the plasma membrane, while Pi-Cav1 signals localized more in the perinuclear region, presumably in caversomes around the pericentrosomal region. In all cases, a colocalization of β-actin and Pi-cav1 on the plasma membrane and pericentrosomal region close to the nucleus, as thread-like structures, can be observed (Figure 8, 4th column). This can be vividly observed as the yellow/orange signals in the overlaid images. This result raised an interesting possibility that the trafficking of Pi-Cav1 may be linked to the β-actin cytoskeleton system.
A similar study was performed to study the relationship between tubulin and Pi-Cav1. Although tubulin staining displayed a random, thread-like network throughout the cytosol in HBMEC, there was no overlapping with Pi-Cav1's long thread-like structures (Figure 8, bottom panels). In the perinuclear staining, there might be some overlap between Pi-Cav1 and tubulin, but it was not significant. Thus, Pi-Cav1 trafficking inside the HBMEC may be a microtubule-independent process.
C. neoformans needs to cross the BBB in order to infect the central nervous system. Unraveling the biological mechanism of C. neoformans invasion across the BBB is crucial to understanding the microbial pathogenesis of this disease. Previous reports have suggested that there are several possible pathways for C. neoformans to enter the host brain [7–9, 11, 12, 14]. If multiple mechanisms exist, then the important question is: which is the major route of cerebral invasion by C. neoformans? Several in vivo studies have provided clues to this mystery. For example, C. neoformans cells could be found in mouse brains after only 5 min following intravenous injection with a low dose of pathogen (104 H99 cells per mouse) . But extravasation of horseradish peroxidase through the BBB could only be detected in mouse brains 6 h after injection with a high dose of pathogen (107 H99 cells per mouse) . Based on the above information, damage to the tight junction or other paracellular mechanism may not be the major method that C. neoformans uses to cross the BBB. In vitro, transmission electron microscopic images show that C. neoformans triggers the formation of microvillus-like membrane protrusions in HBMEC within a short time (15 to 30 min), after which C. neoformans cells were internalized by the cells. They penetrated across the HBMEC monolayers via a transcellular pathway without affecting monolayer integrity . One possible mechanism for this is that fungal transcytosis may be mediated by the fungal hyaluronic acid and host HBMEC CD44 receptor [13, 14]. Collectively, there is an active invasion process(es) allowing fungal cells to effectively traverse the intact BBB. To explore the mechanism of transcellular migration during cerebral invasion by C. neoformans, we studied the host response during this process. In this report, we investigated the interplay among fungal cells, host CD44, membrane lipid rafts and Cav1 to analyze the mechanism of adhesion and invasion by this fungus.
CD44 is the C. neoformans receptor on the lipid rafts/caveolae of HBMEC . Here we initially demonstrated that CD44 was colocalized with Cav1 on the surface of HBMEC (Figure 5), supporting the notion that CD44 exerts its functions on lipid rafts. Lipid rafts are enriched in cholesterol, sphingolipids and raft proteins. These highly dynamic membrane structures may have a potential role as signaling platforms by clustering receptors used by pathogens. Caveolae are a special type of membrane lipid rafts. We therefore investigated whether their major component, Cav1, is involved in the C. neoformans invasion process. We found that the lipid raft marker ganglioside GM1 (Figure 2) can cluster around the C. neoformans adhesion site. Knockdown of Cav1 perturbed GM1 distribution (Figure 2), and, more interestingly, the CD44 proteins became randomly distributed and clustered into irregular islands on the surface of HBMEC (Figure 1B). This unique morphology has never been described in any cell type. As such, C. neoformans invasion into HBMEC is impaired (Figure 3B). The results suggest that Cav1 may play an important structural role in the reorganization of CD44, optimizing it to function as a receptor during C. neoformans invasion. Furthermore, transcytosis of C. neoformans was significantly reduced in the Cav1 knockdown HBMEC (Figure 4). Together, CD44 might be anchored on the lipid rafts/caveolae to form an entry site on the surface of HBMEC during C. neoformans infection. At present, there is no evidence to show a direct interaction between CD44 and Cav1. On the other hand, it has been documented that there is a direct interaction between PKCα and Cav1 , and that activation of PKCα on the plasma membrane is required for C. neoformans invasion into HBMEC . The relationship between Cav1 and PKCα for C. neoformans invasion is interesting, but still needs to be further elucidated.
One interesting question regarding C. neoformans invasion is that the C. neoformans cell is able to hijack the endocytic signaling in HBMEC in order to facilitate its internalization . Notice that endocytosis comprises multiple mechanisms, i.e., caveolae-dependent, clathrin-dependent, pinocytosis, macropinocytosis, and phagocytosis [17–20, 30]. In this report, we first demonstrated the involvement of Cav1 in C. neoformans infection. Perturbation of Cav1 function by knockdown of Cav1 (Figures 3 and 4) can substantially reduce the ability of fungi to invade HBMEC. Cav1 is the major protein constituent of caveolae . Thus, our results support the notion that C. neoformans may utilize the lipid raft/caveolae endocytic pathway for its invasion. Caveolae are small invaginations in the plasma membrane that mediate multiple functions, including signal transduction and endocytosis [19, 30]. Increasing evidence shows that pathogens are able to use lipid rafts or caveolae as cell surface platforms for interacting with, binding to and possibly entering into the host cells . Typical caveolae are 70 to 100 nm in diameter. Sphingolipid binding toxins (cholera toxin CTxB and shiga toxin) and viruses (including SV40) can be carried inside the caveolae cargo, whereas bacteria (> 1 μm in diameter) are much larger than caveolae, which might thus not be suitable to accommodate their engulfment. In this case, the caveolae do not provide the entry route per se , but offer signaling platforms required for the bacterial invasion. The size of C. neoformans is ~5 μm or larger in diameter, depending on its capsule size. It is conceivable that entry of this organism is mediated by its association with lipid rafts, rather than by its enclosure within caveolae per se, and that host Cav1 plays a crucial role of C. neoformans invasion into HBMEC.
We further studied how Cav1 was involved in this invasion process. It has been proposed that, upon the ligand interaction, Cav1 is activated through its phosphorylation regulation [27, 28]. However, the regulation of Cav1 by phosphorylation is poorly understood in the field of the pathogen infection. In our studies, we have found several novel observations about Cav1 phosphorylation regulation. First, phosphorylation of Cav1 is enhanced in the presence of C. neoformans. The peak of phosphorylation is around 10 min at the fungal-host engagement (Figure 6), suggesting that Cav1 is involved during the C. neoformans infection. Secondly, the Cav1 phosphorylation is HA-dependent (Figure 7A), presumably, through the C. neoformans HA to HBMEC CD44 signaling pathway. Thirdly, phosphorylation apparently starts from the lipid rafts, as filipin treatment can reduce its phosphorylation level (Figure 7B); thus, its phosphorylation, most likely, triggers a dynamic internalization process there. Fourthly, a major finding of our study is that the Pi-Cav1 signal is observed as the thread-like structure inside the HBMEC, and this structure is colocalized with β-actin filaments, not with tubulin (Figure 8). It is known that Cav1 can associate with many proteins through its CSD domain, including actin-binding protein such as filamin [35, 36]. In this scenario, activated Cav1 (Pi-Cav1) may be associated with β-actin through this binding domain and internalized into HBMEC. It is tempting to speculate that other signaling molecules may also be internalized via binding with Pi-Cav1 in a similar manner. Thus, Pi-Cav1 may carry certain signaling molecules with it during the internalization process. This speculation remains to be demonstrated.
Our studies demonstrate that C. neoformans is able to manipulate the lipid-raft/caveolae endocytic pathway to facilitate its adhesion and internalization into HBMEC. Cav1 may function as a plasma membrane platform to localize caveolin interacting signaling molecules within caveolae membranes. Our results support a transcellular mechanism for C. neoformans invasion. We are currently investigating Cav1-associated signaling molecules and Cav1 regulation to unravel the profound invasion mechanism of C. neoformans.
cholera toxin subunit B
human brain microvascular endothelial cells
Casadevall A, Pirofski L: Host-pathogen interactions: the attributes of virulence. J Infect Dis. 2001, 184: 337-344. 10.1086/322044.
Lin X, Heitman J: The biology of the Cryptococcus neoformans species complex. Annu Rev Microbiol. 2006, 60: 69-105. 10.1146/annurev.micro.60.080805.142102. 69-105
Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM: Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009, 23: 525-530. 10.1097/QAD.0b013e328322ffac.
Rubin LL, Staddon JM: The cell biology of the blood-brain barrier. Annu Rev Neurosci. 1999, 22: 11-28. 10.1146/annurev.neuro.22.1.11.
Zaragoza O, Rodrigues ML, De Jesus M, Frases S, Dadachova E, Casadevall A: The capsule of the fungal pathogen Cryptococcus neoformans. Adv Appl Microbiol. 2009, 68: 133-216. 133-216
Shi M, Li SS, Zheng C, Jones GJ, Kim KS, Zhou H, Kubes P, Mody CH: Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J Clin Invest. 2010, 120: 1683-1693. 10.1172/JCI41963.
Charlier C, Chretien F, Baudrimont M, Mordelet E, Lortholary O, Dromer F: Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol. 2005, 166: 421-432. 10.1016/S0002-9440(10)62265-1.
Chretien F, Lortholary O, Kansau I, Neuville S, Gray F, Dromer F: Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis. 2002, 186: 522-530. 10.1086/341564.
Jong A, Wu CH, Chen HM, Luo F, Kwon-Chung KJ, Chang YC, Lamunyon CW, Plaas A, Huang SH: Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of C. neoformans infection. Eukaryot Cell. 2007, 6: 1486-1496. 10.1128/EC.00120-07.
Jong A, Wu CH, Prasadarao NV, Kwon-Chung KJ, Chang YC, Ouyang Y, Shackleford GM, Huang SH: Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells requires protein kinase C-alpha activation. Cell Microbiol. 2008, 10: 1854-1865. 10.1111/j.1462-5822.2008.01172.x.
Olszewski MA, Noverr MC, Chen GH, Toews GB, Cox GM, Perfect JR, Huffnagle GB: Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am J Pathol. 2004, 164: 1761-1771. 10.1016/S0002-9440(10)63734-0.
Santangelo R, Zoellner H, Sorrell T, Wilson C, Donald C, Djordjevic J, Shounan Y, Wright L: Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model. Infect Immun. 2004, 72: 2229-2239. 10.1128/IAI.72.4.2229-2239.2004.
Chang YC, Jong A, Huang S, Zerfas P, Kwon-Chung KJ: CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans. Infect Immun. 2006, 74: 3930-3938. 10.1128/IAI.00089-06.
Jong A, Wu CH, Shackleford GM, Kwon-Chung KJ, Chang YC, Chen HM, Ouyang Y, Huang SH: Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells. Cell Microbiol. 2008, 10: 1313-1326. 10.1111/j.1462-5822.2008.01128.x.
Chen HM, Stins SF, Huang HS, Chen YH, Kwon-Chung KJ, Chang YC, Kim KSJA: Cryptococcus neoformans induces alterations in cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol. 2003, 52: 961-970. 10.1099/jmm.0.05230-0.
Huang SH, Long M, Wu CH, Kwon-Chung KJ, Chang YC, Chi F, Lee S, Jong A: Invasion of Cryptococcus neoformans into Human Brain Microvascular Endothelial Cells Is Mediated through the Lipid Rafts-Endocytic Pathway via the Dual Specificity Tyrosine Phosphorylation-regulated Kinase 3 (DYRK3). J Biol Chem. 2011, 286: 34761-34769. 10.1074/jbc.M111.219378.
Lajoie P, Nabi IR: Regulation of raft-dependent endocytosis. J Cell Mol Med. 2007, 11: 644-653. 10.1111/j.1582-4934.2007.00083.x.
Nabi IR, Le PU: Caveolae/raft-dependent endocytosis. J Cell Biol. 2003, 161: 673-677. 10.1083/jcb.200302028.
Parton RG, Richards AA: Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic. 2003, 4: 724-738. 10.1034/j.1600-0854.2003.00128.x.
Parton RG, Simons K: The multiple faces of caveolae. Nat Rev Mol Cell Biol. 2007, 8: 185-194.
Mundy DI, Machleidt T, Ying YS, Anderson RG, Bloom GS: Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton. J Cell Sci. 2002, 115: 4327-4339. 10.1242/jcs.00117.
Williams TM, Lisanti MP: The caveolin proteins. Genome Biol. 2004, 5: 214-10.1186/gb-2004-5-3-214.
Krajewska WM, Maslowska I: Caveolins: structure and function in signal transduction. Cell Mol Biol Lett. 2004, 9: 195-220.
Lee H, Woodman SE, Engelman JA, Volonte D, Galbiati F, Kaufman HL, Lublin DM, Lisanti MP: Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase: targeting of dually acylated molecules (GPI-linked, transmembrane, or cytoplasmic) to caveolae effectively uncouples c-Src and caveolin-1 (TYR-14). J Biol Chem. 2001, 276: 35150-35158. 10.1074/jbc.M104530200.
Lee H, Volonte D, Galbiati F, Iyengar P, Lublin DM, Bregman DB, Wilson MT, Campos-Gonzalez R, Bouzahzah B, Pestell RG, Scherer PE, Lisanti MP: Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol. 2000, 14: 1750-1775. 10.1210/me.14.11.1750.
Wang B, Feng L, Hu Y, Huang SH, Reynolds CP, Wu L, Jong AY: The essential role of Saccharomyces cerevisiae CDC6 nucleotide-binding site in cell growth, DNA synthesis, and Orc1 association. J Biol Chem. 1999, 274: 8291-8298. 10.1074/jbc.274.12.8291.
Joshi B, Strugnell SS, Goetz JG, Kojic LD, Cox ME, Griffith OL, Chan SK, Jones SJ, Leung SP, Masoudi H, Leung S, Wiseman SM, Nabi IR: Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion. Cancer Res. 2008, 68: 8210-8220. 10.1158/0008-5472.CAN-08-0343.
Salatino M, Beguelin W, Peters MG, Carnevale R, Proietti CJ, Galigniana MD, Vedoy CG, Schillaci R, Charreau EH, Sogayar MC, Elizalde PV: Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation. Oncogene. 2006, 25: 7723-7739. 10.1038/sj.onc.1209757.
Williams TM, Lisanti MP: The caveolin proteins. Genome Biol. 2004, 5: 214-10.1186/gb-2004-5-3-214.
Nichols B: Caveosomes and endocytosis of lipid rafts. J Cell Sci. 2003, 116: 4707-4714. 10.1242/jcs.00840.
Chang YC, Stins MF, McCaffery MJ, Miller GF, Pare DR, Dam T, Paul-Satyaseela M, Kim KS, Kwon-Chung KJ: Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun. 2004, 72: 4985-4995. 10.1128/IAI.72.9.4985-4995.2004.
Oka N, Yamamoto M, Schwencke C, Kawabe J, Ebina T, Ohno S, Couet J, Lisanti MP, Ishikawa Y: Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide. J Biol Chem. 1997, 272: 33416-33421. 10.1074/jbc.272.52.33416.
Schelhaas M, Malmstrom J, Pelkmans L, Haugstetter J, Ellgaard L, Grunewald K, Helenius A: Simian Virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell. 2007, 131: 516-529. 10.1016/j.cell.2007.09.038.
Pelkmans L, Burli T, Zerial M, Helenius A: Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell. 2004, 118: 767-780. 10.1016/j.cell.2004.09.003.
Popowicz GM, Schleicher M, Noegel AA, Holak TA: Filamins: promiscuous organizers of the cytoskeleton. Trends Biochem Sci. 2006, 31: 411-419. 10.1016/j.tibs.2006.05.006.
Stahlhut M, van Deurs B: Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton. Mol Biol Cell. 2000, 11: 325-337.
We thank Jennifer Liu for critical reading. We also thank Dr. Casadevall for providing us with the anti-GXM monoclonal antibody (#18b7). This project is financially supported by Public Health Service grants R01-NS047599 (A.J.) and R01-AI40635 (S.H.H.).
The authors declare that they have no competing interests.
ML and CW performed immunofluorescence microscope. SHH carried out Western blots and statistical analyses. GMS studied the phosphorylation. AJ designed the experiments, and he is the principal investigator of this project. All authors read and approved the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Long, M., Huang, SH., Wu, CH. et al. Lipid raft/caveolae signaling is required for Cryptococcus neoformans invasion into human brain microvascular endothelial cells. J Biomed Sci 19, 19 (2012). https://doi.org/10.1186/1423-0127-19-19
- Cryptococcus neoformans
- brain microvascular endothelial cells
- lipid raft